AdipoGen Life Sciences Notch signalling research reagents
The Notch signalling pathway regulates many different cell fate decisions in both vertebrate and invertebrate species. Deregulations in Notch signalling components have been associated with various human disorders such as cancer, immune disorders, developmental syndromes, stroke and cognitive symptoms.
AdipoGen Life Sciences brings a comprehensive range of Notch signalling reagents to the market. Products include Notch receptors (Notch 1 and 2), canonical Notch ligands (DLL1, DLL3 and DLL4), non-classical Notch ligands (DLK1 and DLK2), E3 ubiquitin ligases, deubiquitinating enzymes and Notch inhibitors.
The reagents are suitable for scientists requiring tools for cancer, T cell and developmental biology research.
Phone: 02 9698 2022
Cayman Chemical Kinase Screening Library (96-Well)
Cayman Chemical's Kinase Screening Library (96-Well) consists of two plates and contains...
AdipoGen Life Sciences GLP-1, GIP and GCG receptor agonists
AdipoGen's range of GLP-1, GIP and GCG receptor agonists includes Liraglutide, Retatrutide,...
Integrated DNA Technologies xGen Hybridization and Wash v3 Kit
Integrated DNA Technologies (IDT) has unveiled its xGen Hybridization and Wash v3 Kit — a...
